The appointments of our new board members in the US and the latest biotech investor invitation speak for themselves.
The next two months should provide some clarity you might seek in form of toxicity and other anns forthcoming.
What is of particular interest here is that Mr. Haddock has lead Array Biopharma previously to a 11.4 billion acquisition by Pfizer.
Whilst some technical details are outstanding, the appointments of a high calibre team to lead PYC towards a billion dollar MC company are compelling.
The additional drug pipelines will be the main price trigger, as I see it.
all IMO
PYC Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)